Fig. 7
From: Treatment of a chemoresistant neuroblastoma cell line with the antimalarial ozonide OZ513
a Time to development and incidence of BE (2)-c tumors after injection of 1 × 106 BE (2)-c cells subcutaneously (b) Average tumor development and growth rate